loading
前日終値:
$0.875
開ける:
$0.88
24時間の取引高:
513.64K
Relative Volume:
0.41
時価総額:
$66.52M
収益:
$101.21M
当期純損益:
$-569.00K
株価収益率:
-42.50
EPS:
-0.02
ネットキャッシュフロー:
$-56.88M
1週間 パフォーマンス:
-4.61%
1か月 パフォーマンス:
-17.48%
6か月 パフォーマンス:
-38.41%
1年 パフォーマンス:
-44.44%
1日の値動き範囲:
Value
$0.84
$0.9191
1週間の範囲:
Value
$0.815
$0.9191
52週間の値動き範囲:
Value
$0.79
$5.85

Cytomx Therapeutics Inc Stock (CTMX) Company Profile

Name
名前
Cytomx Therapeutics Inc
Name
セクター
Healthcare (1173)
Name
電話
650.515.3185
Name
住所
151 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
Name
職員
122
Name
Twitter
@cytomxinc
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
CTMX's Discussions on Twitter

CTMX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
CTMX
Cytomx Therapeutics Inc
0.85 66.52M 101.21M -569.00K -56.88M -0.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
461.68 118.90B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
672.98 73.95B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
655.13 39.81B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
271.31 34.99B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
123.77 29.67B 3.30B -501.07M 1.03B -2.1146

Cytomx Therapeutics Inc Stock (CTMX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-05-28 アップグレード Piper Sandler Neutral → Overweight
2024-05-09 アップグレード Wedbush Neutral → Outperform
2024-05-06 アップグレード Jefferies Hold → Buy
2024-04-22 アップグレード JP Morgan Underweight → Neutral
2022-11-14 ダウングレード BMO Capital Markets Outperform → Market Perform
2022-07-07 ダウングレード Jefferies Buy → Hold
2022-07-07 ダウングレード Mizuho Buy → Neutral
2022-07-07 ダウングレード Piper Sandler Overweight → Neutral
2022-07-07 ダウングレード Wedbush Outperform → Neutral
2022-06-24 開始されました BMO Capital Markets Outperform
2022-01-18 アップグレード Barclays Underweight → Overweight
2021-11-15 開始されました BTIG Research Buy
2021-05-28 ダウングレード Barclays Equal Weight → Underweight
2021-03-29 開始されました JP Morgan Overweight
2021-03-23 アップグレード Jefferies Hold → Buy
2020-09-22 ダウングレード Guggenheim Buy → Neutral
2020-06-01 ダウングレード Jefferies Buy → Hold
2020-05-14 繰り返されました H.C. Wainwright Buy
2020-03-24 アップグレード Wedbush Neutral → Outperform
2020-03-04 開始されました Barclays Equal Weight
2019-11-20 開始されました Guggenheim Buy
2019-11-11 ダウングレード Wedbush Outperform → Neutral
2019-06-13 開始されました Mizuho Buy
2019-05-14 開始されました Cantor Fitzgerald Overweight
2019-03-11 開始されました Barclays Overweight
2018-11-26 開始されました Piper Jaffray Overweight
2018-10-15 開始されました Goldman Neutral
2018-09-13 開始されました H.C. Wainwright Buy
2018-06-01 開始されました SunTrust Buy
2018-01-05 開始されました Citigroup Buy
2017-09-08 開始されました Wedbush Outperform
2017-03-27 開始されました H.C. Wainwright Buy
2017-03-02 開始されました Instinet Buy
2017-01-03 ダウングレード Oppenheimer Outperform → Perform
2015-11-02 開始されました Oppenheimer Outperform
すべてを表示

Cytomx Therapeutics Inc (CTMX) 最新ニュース

pulisher
Jan 29, 2025

Shareholders in CytomX Therapeutics (NASDAQ:CTMX) are in the red if they invested five years ago - Yahoo Finance

Jan 29, 2025
pulisher
Jan 25, 2025

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Shares Sold by Assenagon Asset Management S.A. - MarketBeat

Jan 25, 2025
pulisher
Jan 25, 2025

Assenagon Asset Management S.A. Sells 1,044,318 Shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Defense World

Jan 25, 2025
pulisher
Jan 23, 2025

Keros Therapeutics Stock Plunges 81% in 3 Months: Here's Why - Yahoo Finance

Jan 23, 2025
pulisher
Jan 20, 2025

Short Interest in CytomX Therapeutics, Inc. (NASDAQ:CTMX) Drops By 13.4% - MarketBeat

Jan 20, 2025
pulisher
Jan 17, 2025

Jane Street Group LLC Decreases Stock Holdings in CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Defense World

Jan 17, 2025
pulisher
Jan 17, 2025

Brokerages Set CytomX Therapeutics, Inc. (NASDAQ:CTMX) Price Target at $5.77 - Defense World

Jan 17, 2025
pulisher
Jan 15, 2025

Bay Area biotech firm CytomX, once worth $2.3 billion, lays off 40% of staff - MSN

Jan 15, 2025
pulisher
Jan 14, 2025

CytomX stock plunges to 52-week low, touches $0.83 By Investing.com - Investing.com Canada

Jan 14, 2025
pulisher
Jan 14, 2025

CytomX stock plunges to 52-week low, touches $0.83 - Investing.com India

Jan 14, 2025
pulisher
Jan 14, 2025

Brokerages Set CytomX Therapeutics, Inc. (NASDAQ:CTMX) Target Price at $5.77 - MarketBeat

Jan 14, 2025
pulisher
Jan 13, 2025

Bay Area biotech firm once worth $2.3 billion lays off 40% of staff - SFGATE

Jan 13, 2025
pulisher
Jan 11, 2025

Geode Capital Management LLC Has $948,000 Stock Position in CytomX Therapeutics, Inc. (NASDAQ:CTMX) - Defense World

Jan 11, 2025
pulisher
Jan 10, 2025

CytomX Therapeutics’ (CTMX) Neutral Rating Reiterated at HC Wainwright - Defense World

Jan 10, 2025
pulisher
Jan 08, 2025

Finance Watch: Generation Bio, CytomX Right-Size Operations Ahead Of J.P. Morgan - News & Insights

Jan 08, 2025
pulisher
Jan 08, 2025

HOTH Stock Soars as Skin Toxicity Study in Cancer Patients Meets Goal - Nasdaq

Jan 08, 2025
pulisher
Jan 08, 2025

CytomX Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 08, 2025
pulisher
Jan 08, 2025

CytomX Therapeutics CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 08, 2025
pulisher
Jan 07, 2025

CytomX falls after portfolio shakeup, job cuts - MSN

Jan 07, 2025
pulisher
Jan 07, 2025

CytomX Therapeutics' SWOT analysis: oncology biotech's stock faces pivotal year - Investing.com

Jan 07, 2025
pulisher
Jan 07, 2025

CytomX stock falls on portfolio shakeup (CTMX:NASDAQ) - Seeking Alpha

Jan 07, 2025
pulisher
Jan 07, 2025

All You Need to Know About CytomX Therapeutics (CTMX) Rating Upgrade to Strong Buy - Yahoo Finance

Jan 07, 2025
pulisher
Jan 07, 2025

CytomX to Cut 40% of Staff as It Updates Pipeline Priorities - BioSpace

Jan 07, 2025
pulisher
Jan 07, 2025

CytomX Therapeutics (NASDAQ:CTMX) Receives "Neutral" Rating from HC Wainwright - MarketBeat

Jan 07, 2025
pulisher
Jan 06, 2025

CytomX refocuses on key cancer drug, extends cash runway - Investing.com India

Jan 06, 2025
pulisher
Jan 06, 2025

CTMXCytomX Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Jan 06, 2025
pulisher
Jan 06, 2025

CytomX announces restructuring, staff cuts to extend cash runway - Investing.com

Jan 06, 2025
pulisher
Jan 06, 2025

CytomX announces restructuring, staff cuts to extend cash runway By Investing.com - Investing.com South Africa

Jan 06, 2025
pulisher
Jan 06, 2025

CytomX refocuses on key cancer drug, extends cash runway By Investing.com - Investing.com Canada

Jan 06, 2025
pulisher
Jan 06, 2025

Peninsula biotech to lay off 40% of workforce as it restructures - The Business Journals

Jan 06, 2025
pulisher
Jan 06, 2025

CytomX Therapeutics to Cut 40% of Workforce - MarketWatch

Jan 06, 2025
pulisher
Jan 06, 2025

CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update - The Manila Times

Jan 06, 2025
pulisher
Jan 03, 2025

CAPR Stock Up on Completion of Rolling Submission of DMD Drug BLA - Zacks Investment Research

Jan 03, 2025
pulisher
Dec 31, 2024

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Short Interest Up 26.2% in December - MarketBeat

Dec 31, 2024
pulisher
Dec 23, 2024

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives $5.77 Average Price Target from Analysts - Defense World

Dec 23, 2024
pulisher
Dec 21, 2024

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Position Raised by Fmr LLC - Defense World

Dec 21, 2024
pulisher
Dec 20, 2024

Emergent (EBS) Gets $235.8M DoD Contract for Anthrax Vaccine - MSN

Dec 20, 2024
pulisher
Dec 20, 2024

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Dec 20, 2024
pulisher
Dec 18, 2024

CytomX Therapeutics (NASDAQ:CTMX) Stock Crosses Below 200 Day Moving AverageHere's What Happened - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

SNY's Tolebrutinib Gets FDA Breakthrough Therapy Tag for nrSPMS - MSN

Dec 18, 2024
pulisher
Dec 17, 2024

CytomX Therapeutics, Inc.'s (NASDAQ:CTMX) Shares Bounce 26% But Its Business Still Trails The Industry - Simply Wall St

Dec 17, 2024
pulisher
Dec 16, 2024

CytomX Therapeutics (CTMX) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Yahoo Finance

Dec 16, 2024
pulisher
Dec 13, 2024

CytomX Therapeutics' SWOT analysis: biotech stock's solid tumor focus By Investing.com - Investing.com Canada

Dec 13, 2024
pulisher
Dec 10, 2024

Janus Henderson Group PLC Trims Stake in CytomX Therapeutics, Inc. (NASDAQ:CTMX) - MarketBeat

Dec 10, 2024
pulisher
Dec 06, 2024

Recent uptick might appease CytomX Therapeutics, Inc. (NASDAQ:CTMX) institutional owners after losing 21% over the past year - Simply Wall St

Dec 06, 2024
pulisher
Nov 30, 2024

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Short Interest Down 21.7% in November - MarketBeat

Nov 30, 2024
pulisher
Nov 28, 2024

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives $5.77 Consensus Price Target from Brokerages - Defense World

Nov 28, 2024
pulisher
Nov 27, 2024

CytomX Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference - The Manila Times

Nov 27, 2024

Cytomx Therapeutics Inc (CTMX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Cytomx Therapeutics Inc (CTMX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Landau Jeffrey B
Chief Business Officer
Aug 20 '24
Sale
1.23
4,181
5,139
119,056
BELVIN MARCIA
SVP, Chief Scientific Officer
Aug 20 '24
Option Exercise
0.00
11,250
0
179,829
BELVIN MARCIA
SVP, Chief Scientific Officer
Aug 20 '24
Sale
1.23
4,181
5,139
175,648
ROWLAND LLOYD A
General Counsel
Aug 20 '24
Option Exercise
0.00
11,250
0
134,978
ROWLAND LLOYD A
General Counsel
Aug 20 '24
Sale
1.23
4,181
5,139
130,797
Ogden Christopher
Chief Financial Officer
Aug 20 '24
Option Exercise
0.00
6,875
0
110,061
Ogden Christopher
Chief Financial Officer
Aug 20 '24
Sale
1.23
1,984
2,439
108,077
McCarthy Sean A.
CEO
Aug 20 '24
Option Exercise
0.00
37,500
0
671,749
McCarthy Sean A.
CEO
Aug 20 '24
Sale
1.23
13,898
17,082
657,851
McCarthy Sean A.
CEO
Mar 26 '24
Option Exercise
1.57
109,768
172,874
634,249
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
大文字化:     |  ボリューム (24 時間):